Ginkgo Bioworks Holdings, Inc.
DNA
$7.54
-$0.27-3.46%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -50.76% | 58.43% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -50.76% | 58.43% | |||
| Cost of Revenue | -19.84% | -12.52% | |||
| Gross Profit | -55.58% | 81.34% | |||
| SG&A Expenses | -0.59% | -15.35% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.35% | -32.87% | |||
| Operating Income | -80.15% | 66.13% | |||
| Income Before Tax | -89.97% | 73.83% | |||
| Income Tax Expenses | 13.33% | -297.37% | |||
| Earnings from Continuing Operations | -90.65% | 74.03% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -90.65% | 74.03% | |||
| EBIT | -80.15% | 66.13% | |||
| EBITDA | -123.69% | 74.38% | |||
| EPS Basic | -85.07% | 74.46% | |||
| Normalized Basic EPS | -108.84% | 72.12% | |||
| EPS Diluted | -85.00% | 74.47% | |||
| Normalized Diluted EPS | -108.84% | 72.11% | |||
| Average Basic Shares Outstanding | 3.01% | 1.69% | |||
| Average Diluted Shares Outstanding | 3.00% | 1.69% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
